- Robot
- open access
- GSL/OTC & Rx
- Prescription Required
For information purpose only - these preparations are not or are not yet available
(†) indicates a preparation that is either no longer authorized, manufactured or marketed.
(*) indicates a preparation that was recently authorized
(») indicates a preparation that is temporarily suspended
(†) indicates a preparation that is either no longer authorized, manufactured or marketed.
(*) indicates a preparation that was recently authorized
(») indicates a preparation that is temporarily suspended
1. (†)
Rayere (Mexico)
Oxymetazoline (refer to Oxymetazoline Hydrochloride )
nasal congestion
2.
Pierre fabre (France)
Fluvastatin sodium
hypercholesterolaemia , cardiovascular risk reduction following coronary angioplasty
3.
Janssen-cilag (Argentina)
Lincomycin
respiratory-tract infections
4.
Pfizer (Brazil)
Lincomycin hydrochloride
bacterial infections
5. (†)
Reig jofre (Spain)
Procaine
benzylpenicillin
bacterial infections
6.
Thea (Portugal)
Chromocarb diethylamine
capillary fragility
7. (†)
Christiaens (Belgium)
Neomycin sulfate
rhinitis , sinusitis
8. (†)
Labaz (France)
Benzarone
peripheral vascular disorders
9. (†)
Sanofi winthrop (Belgium)
Benzarone
peripheral vascular disorders
10. (†)
Sanol (Germany)
Benzarone
vascular disorders
11.
Pfizer (United Kingdom, Sweden, Switzerland, Netherlands, Belgium, Spain, Norway, Austria, Australia, United States, Canada, Denmark, Portugal, Hong Kong, Singapore, Finland, New Zealand, Brazil, Greece, Chile, Hungary, Czech Republic, Mexico, Venezuela, Turkey, Poland, Philippines, Romania)
Dalteparin sodium
prevention of clotting during haemodialysis or haemofiltration , thromboembolic disorders , unstable angina
12.
Pharmacia (Germany, Italy, South Africa, Israel, Russia)
Dalteparin sodium
thromboembolic disorders , prevention of clotting during haemodialysis and haemofiltration
13.
Pfizer (France)
Dalteparin sodium
thromboembolic disorders , prevention of clotting during haemodialysis , unstable angina , myocardial infarction
14.
Arrow (Australia)
Doxycycline
bacterial infections , amoebiasis , malaria
15. (†)
Bausch & lomb (Switzerland)
Framycetin sulfate
bacterial eye infections
16.
Medic+aid (Philippines)
Rifampicin
tuberculosis , nasopharyngeal carriers of neisseria meningitidis
17.
Levofarma (Italy)
Cefonicid sodium
gram-negative bacterial infections
18. (†)
Gedeon richter (Czech Republic, Russia)
Fluoxetine hydrochloride
depression , obsessive-compulsive disorder , bulimia nervosa
19. (†)
Pharlab (Brazil)
Lincomycin
gram-positive bacterial infections
20. (†)
Cassenne (France)
Framycetin sulfate
burns , wounds
21. (†)
Martin (France)
Framycetin sulfate
rhinopharyngeal infections
22. (†)
Fisons (United Kingdom)
Framycetin sulfate
bacterial skin and eye infections , otitis externa
23.
Mochida (Japan)
Neomycin sulfate
bacterial infections
24. (†)
Francia (Italy)
Methacycline hydrochloride
bacterial infections
25. (†)
Francia (Italy)
Fosfomycin calcium
bacterial infections
26. (†)
Nuovo (Italy)
Methacycline hydrochloride
bacterial infections
27.
Sanofi synthelabo (Thailand)
Theophylline
obstructive airways disease
28. (†)
Johnson & johnson msd consumer (United Kingdom)
Dextromethorphan hydrobromide
coughs
29.
Francia (Italy)
Ursodeoxycholic acid
gallstones , biliary disorders
30. (†)
Francia (Italy)
Hydroxocobalamin
anaemias , peripheral neuropathies , liver disorders
31.
Sanofi synthelabo (Switzerland)
Nadroparin calcium
deep-vein thrombosis
32.
Gsk (Germany, Austria)
Nadroparin calcium
thromboembolic disorders , prevention of clotting during haemodialysis and haemofiltration
33.
Gsk (Italy, Portugal, Venezuela, Spain)
Nadroparin calcium
prevention of clotting during haemodialysis , thromboembolic disorders , unstable angina pectoris
34.
Sanofi-aventis (Brazil)
Nadroparin calcium
thromboembolic disorders
35.
Gsk (Netherlands, Switzerland, Belgium, Hong Kong, Thailand, Canada, New Zealand, Malaysia, Argentina, Greece, Chile, Hungary, Czech Republic, France, Russia, Turkey, Poland, Philippines, Indonesia)
Nadroparin calcium
thromboembolic disorders
36. (†)
Sanofi synthelabo (Australia, Sweden, Mexico, Norway, Singapore, Israel, South Africa)
Nadroparin calcium
deep-vein thrombosis
37. (†)
Sanofi winthrop (Denmark, Finland)
Nadroparin calcium
thromboembolic disorders
38. (†)
Ursapharm (Germany)
Oxedrine hydrochloride
eye disorders
39.
Gsk (France, Netherlands, Germany, Hungary, Belgium, Turkey, Italy, Poland, Portugal)
Nadroparin calcium
thromboembolic disorders
40.
Sanofi synthelabo (Mexico)
Nadroparin calcium
venous thrombosis
41. (†)
Ranbaxy (South Africa)
Ceftriaxone (refer to Ceftriaxone Sodium )
bacterial infections
42. (†)
Francia (Italy)
Pirenzepine hydrochloride
peptic ulcer
43.
Ferron (Indonesia)
Ondansetron
nausea and vomiting
44.
Altana (Greece)
Ciclesonide
obstructive airways disease